For informational purposes only — not investment advice

← Back to signals

VGNT

LONGINSIDER SELL

VERSIGENT PLC

Research: Finviz ↗·Perplexity ↗

Funds
3
Score
3.64
vs SPY
+8.8%
Stock return (since Q-end)
+12.8%
SPY return (since Q-end)
+4.0%
Current price
$47.27
Days to cover (short int.)
4.7d↓-11.1%
as of 2026-09-15

News Summary

Positive

Versigent delivered a strong Q2 2026 earnings beat (EPS $1.92 vs. $1.51 estimate, +27%), raised full-year revenue guidance to $9.4B–$9.6B, and initiated a quarterly dividend while maintaining a $250M buyback authorization. However, the post-earnings rally has been partially reversed by insider profit-taking ($5.7M in Form 4 sales), a contrarian downgrade at Fox Advisors, and profit-locking by institutional investors, signaling some near-term valuation concerns despite operational strength.

Red flags

  • •Insider share sales exceeding $5.7 million post-earnings, suggesting potential valuation concern at current levels
  • •Fox Advisors downgrade to Equal-Weight (Aug 5) immediately after earnings beat, providing contrarian view vs. broader analyst upgrades
  • •Profit-taking and share weakness following institutional stake accumulation, indicating possible near-term overheating of valuation

Funds Buying (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Greenlight CapitalDavid Einhorn2.3M+2.3M$96M2.4%—NEW
Soros Fund ManagementSoros Family Office584K+584K$25M0.3%—NEW
Point72Steve Cohen232K+232K$10M<0.1%—NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where VGNT ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Greenlight Capital

position #13 of this fund's book

  1. 10GRAPHIC PACKAGING HLDG CO$105M
  2. 11TD SYNNEX CORPORATION$102M
  3. 12TEVA PHARMACEUTICAL INDS LTD$98M
  4. 13VERSIGENT PLC$96M
  5. 14CAPRI HOLDINGS LIMITED$90M
  6. 15BKV CORP$85M
  7. 16DHT HOLDINGS INC$83M

Values are quarter-end position sizes. Shown only for funds where VGNT ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
CLARK KEVIN P—SELL58K$45.49$2.62M2026-09-09↗
CLARK KEVIN P—SELL17K$46.27$0.76M2026-09-09↗
CLARK KEVIN P—SELL105$47.08$0.00M2026-09-09↗
CLARK KEVIN P—SELL38K$47.85$1.83M2026-09-08↗
CLARK KEVIN P—SELL9K$48.50$0.44M2026-09-08↗
CLARK KEVIN P—SELL1K$49.67$0.06M2026-09-08↗

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
Vanguard Portfolio ManagementSC 13G4.3M6.0%2026-07-31↗
Vanguard Capital ManagementSC 13G3.9M5.5%2026-07-31↗
BlackRock, Inc.SC 13G/A10.6M15.0%2026-07-30↗
BlackRock, Inc.SC 13G8.1M11.4%2026-05-06↗

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.